Figure 3.
Funnel plots showing no significant publication bias in the different subgroups. (A) Arrhythmic events: flecainide monotherapy versus standard therapy; (B) arrhythmic events: combination therapy versus β-blocker monotherapy; (C) symptomatic events: combination therapy versus β-blocker monotherapy; (D) side effects: flecainide versus β-blocker.